TOG Review (RCOG Journal)
MRCOG Part 2
Antenatal Care
Prenatal genomic testing for ultrasound-detected fetal structural anomalies
Key Statistics
- 3–5% — Pregnancies affected by FSA
- 0.5% — Miscarriage risk, invasive testing
- ≤80% — Max diagnostic yield, exome sequencing
Don't-miss facts
-
FSAs affect 3–5% of pregnancies; ~50% have a genetic/chromosomal cause
-
Testing order: QF-PCR (48h) → karyotype (~10d, gold standard for mosaicism/rearrangements) or CMA (10–14d, +3.5– 6% yield) → trio exome sequencing (10–14d)
-
CMA offered with normal QF-PCR plus NT ≥3.5 mm (CRL 45–84 mm), ≥1 FSA, or unexplained sex chromosome aneuploidy; commonest CNV = 22q11.2 deletion
-
PAGE study (n=610): diagnostic ES yield 8.5%, VUS 3.9%; key genes KMT2D, CHD7, PTPN11
-
R21 rapid exome requires normal QF-PCR + CMA first; not used if TOP decided or fetal demise imminent
-
Only class IV/V variants reported as diagnostic (Sanger-validated); VUS not reported but may be reclassified
-
Invasive testing miscarriage risk 0.5%; maternal cell contamination 1–2%
-
Recurrence: autosomal recessive 1/4, autosomal dominant 1/2, gonadal mosaicism up to 4% even if "de novo"
Testing tiers at a glance
QF-PCR 48h → ~25% yield CMA 10–14d → +3.5–6% yield Exome sequencing 10–14d → up to 80% (selected)
Abbreviation Key
- FSA — fetal structural anomaly
- FISH — fluorescence in situ hybridization
- QF-PCR — quantitative fluorescence-polymerase chain reaction
- CVS — chorionic villus sampling
- CMA — chromosome microarray
- TAT — turnaround time
- CGH — comparative genomic hybridisation
- NT — nuchal translucency
- SNP — single nucleotide polymorphism
- MDT — multidisciplinary team
- CNV — copy number variant
- NIPD — non-invasive prenatal diagnosis
- NGS — next generation sequencing
- PGD — preimplantation genetic diagnosis
- ES — exome sequencing
- RCOG — Royal College of Obstetricians and Gynaecologists
- WGS — whole genome sequencing
- PAGE — Prenatal Assessment of Genomes and Exomes study
- VUS — variant of uncertain significance
- R21 — NHS England rapid prenatal exome test code
Source: Reilly K et al. Prenatal genomic testing for ultrasound-detected fetal structural anomalies. The Obstetrician & Gynaecologist 2023;25:121–130. doi:10.1111/tog.12870
MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).